Article Information
History
- July 22, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Shaul Lev1,2,
- Tamar Gottesman1,2,
- Gal Sahaf Levin1,2,
- Doron Lederfein3,
- Evgeny Berkov3,
- Dror Diker3,
- Aliza Zaidman3,
- Amir Nutman4,
- Tahel Ilan Ber5,
- Alon Angel5,
- Lior Kellerman5,
- Eran Barash5,
- Roy Navon5,
- Olga Boico5,
- Yael Israeli5,
- Michal Rosenberg5,
- Amir Gelman5,
- Roy Kalfon5,
- Einav Simon5,
- Noa Avni5,
- Mary Hainrichson5,
- Oren Zarchin5,
- Tanya M. Gottlieb5,
- Kfir Oved5,
- Eran Eden5,* and
- Boaz Tadmor1,2
- 1Intensive Care Unit, Rabin Medical Center, Hasharon, Petah Tikva, Israel
- 2Sackler Faculty of Medicine, Tel Aviv University, Israel
- 3Internal Medicine, Rabin Medical Center, Hasharon, Petah Tikva, Israel
- 4National Institute for Infection Control and Antibiotic Resistance, Tel Aviv Medical Centre, Tel-Aviv, Israel
- 5MeMed, Haifa, Israel
- ↵*Corresponding author; Email: eraneden{at}me-med.com
Posted July 22, 2020.
Real-time IP-10 measurements as a new tool for inflammation regulation within a clinical decision support protocol for managing severe COVID-19 patients
